The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndrome

Scandinavian Cardiovascular Journal

Volumn 37, Issue 1, 2003, Pages 18-22

  Yongzhong, Wang ^a   Johnsen, Hans E ^b   Jørgensen, Erik ^a   Kastrup, Jens ^a  

^a Mental Health Services CPH   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; BLOOD CLOT LYSIS; CELL COUNT; CLINICAL TRIAL; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ST SEGMENT ELEVATION; STEM CELL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOGENIC PROTEINS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; HUMANS; MYOCARDIAL INFARCTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0038664137     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430310006983     Document Type: Review

References (31)

1. Kastrup J, Jørgensen E, Drvota V. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis. Scand Cardiovasc J 2001; 35: 291-296.
2. Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 30(105): 2012-2018.
3. Kastrup J, Jørgensen E, Drvota V, et al, and the Euroinject One group. Intramyocardial injection of genes by a novel percutaneous technique. Initial safety data in the Euroinject One study. Heart/Drug 2001; 1: 299-304.
4. Kalka C, Tehrani H, Laudenberg B, et al. Mobilization of endothelial progenitor cells following gene therapy with VEGF165 in patients with inoperable coronary disease. Ann Thorac Surg 2000; 70: 829-834.
5. Takahashi T, Kalka C, Masuda H, et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
6. Houck KA, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-1814.
7. Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94: 610-613.
8. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997; 3: 158-163.
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
10. Fina L, Molgaard HV, Robertson D, et al. Expression of CD34 gene in vascular endothelial cells. Blood 1990; 75: 2417-2426.
11. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
12. Shweiki D, Itin DA, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
13. Levy AP, Levy NS, Loscalzo J, et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 1995; 76: 758-766.
14. Brogi E, Wu T, Namiki A, et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-652.
15. Ogawa H, Suefuji H, Soejima H, et al. Increased blood vascular endothelial growth factor level in patients with acute myocardial infarction. Cardiology 2000; 93(1-2): 93-99.
16. Soeki T, Tamura Y, Shinohara H, et al. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 2000; 93(3): 168-174.
17. Kranz A, Rao C, Kochs M, et al. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 2000; 32: 65-72.
18. Seko Y, Imai Y, Suzuki S, et al. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997; 92: 453-454.
19. Cuevas P, Barrios V, Gimenez-Gallego G, et al. Serum levels of basic fibroblast growth factor in acute myocardial infarction. Eur J Med Res 1997 Jul 28; 2(7): 282-284.
20. Tamura K, Nakajima H, Rakue H, et al. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 1999; 63(5): 357-361.
21. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103(23): 2776.
22. Isner JM, Kalka C, Kawamoto A, Asahara T. Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair [Review]. Ann NY Acad Sci 2001 Dec; 953: 75-84.
23. Uchida Y, Yanagisawa-Miwa A, Nakamura F, et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J 1995; 130: 1182-1188.
24. Landau C, Jacobs AK, Haudenschild CC, et al. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 1995; 129: 924-931.
25. Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327: 1825-1831.
26. Lee SH, Paul L, Wolf et al. Early expression of angiogenesis factors in acute myocardial infarction. N Engl J Med 2000; 342: 626-633.
27. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897-903.
28. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardio-myocyte apoptosis, reduces remodelling and improves cardiac function. Nat Med 2001; 7: 430-436.
29. Seiler C, Tilmann P, Wustmann K, et al. Promotion of collateral growth by granulocyt-macrophage colony-stimulating factor in patients with coronary artery disease. Circulation 2001; 104: 2012-2017.
30. Iversen PO. Blood flow to bone marrow. Acta Physiol Scand 1997; 159(4): 269-276.
31. Jensen KE, Hansen PB, Larsen VA, et al. Short-term myeloid growth factor mediated expansion of bone marrow haemopoiesis studied by localized magnetic resonance proton spectroscopy. Br J Haematol 1994; 88: 465-471.